Franklin Resources Inc ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) - 13F, 13D, 13G Filings

Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

AT ˙ WBAG ˙ US8816242098

29,40 € ↑1,40 (5,00%)

2026-06-04
CENA AKCJI

Security	AT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
Institution	Franklin Resources Inc
Latest Disclosed Ownership	19,916,016 shares
Ownership	1.80%

Franklin Resources Inc ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

2020-02-05 - Franklin Resources Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 19,916,016 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (AT:TEVA). This represents 1.8 percent ownership of the company. In their previous filing dated 2019-01-28 , Franklin Resources Inc had reported owning 64,128,532 shares, indicating a decrease of -68.94 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2020-02-05	2020-02-05	13G/A	64,128,532	19,916,016	-68.94	1.80	-71.43
2019-01-28	2019-01-28	13G/A	70,601,691	64,128,532	-9.17	6.30	0.00
2018-02-05	2018-02-05	13G		70,601,691		6.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-13	2026-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	732,290	715,150	4,172.40	22,057	4,030.34	0.0009
2026-02-11	2025-12-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	17,140	65	0.38	535	55.23	0.0001
2025-11-13	2025-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	17,075	1,850	12.15	345	34.90	0.0001
2025-08-12	2025-06-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	15,225	15,225		255		0.0001
2025-05-13	2025-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	0	-46,826	-100.00	0	-100.00
2025-02-12	2024-12-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	46,826	-108,265	-69.81	1,032	-61.39	0.0003
2024-11-27	2024-09-30	13F/A-1	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	155,091	90,920	141.68	2,674	156.53	0.0008
2024-11-12	2024-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	155,091	90,920		2,674		0.0001
2024-08-14	2024-06-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	64,171	64,171		1,043		0.0003
2022-02-11	2021-12-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	0	-12,289	-100.00	0	-100.00
2021-11-12	2021-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	12,289	-7,691	-38.49	120	-39.39	0.0000
2021-08-13	2021-06-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	19,980	5,487	37.86	198	18.56	0.0001
2021-05-13	2021-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	14,493	-162,181	-91.80	167	-90.21	0.0001
2021-02-10	2020-12-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	176,674	162,806	1,173.97	1,705	1,264.00	0.0007
2020-11-12	2020-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	13,868	13,868		125		0.0001
2020-05-13	2020-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	0	-19,916,016	-100.00	0	-100.00
2020-03-11	2019-12-31	13F/A-1	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	19,916,016	-21,560,376	-51.98	195,177	-31.60	0.1025
2020-02-12	2019-12-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	19,916,016	-21,560,376		195,177		103,117.0914
2019-11-14	2019-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	41,476,392	-20,166,739	-32.72	285,357	-49.85	0.1550
2019-08-14	2019-06-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	61,643,131	-2,980,753	-4.61	568,959	-43.85	0.3026
2019-05-15	2019-03-31	13F/A-1	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	64,623,884	-1,483,372	-2.24	1,013,298	-0.60	0.5427
2019-05-14	2019-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADS	881624209	64,623,884	-1,483,372		1,013,298
2019-02-12	2018-12-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	66,107,256	-426,849	-0.64	1,019,435	-28.86	0.6153
2018-11-13	2018-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	66,534,105	-5,690,773	-7.88	1,433,084	-18.42	0.7134
2018-08-14	2018-06-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	72,224,878	-907,895	-1.24	1,756,573	40.54	0.9011
2018-05-10	2018-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	73,132,773	-6,355,366	-8.00	1,249,835	-17.03	0.6336
2018-02-14	2017-12-31	13F	TEVA PHARMACEUTICAL INDs	SPONSORED ADR	881624209	79,488,139	6,009,897	8.18	1,506,309	16.48	0.7228
2017-11-13	2017-09-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	73,478,242	6,681,345	10.00	1,293,145	-41.72	0.6339
2017-08-10	2017-06-30	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	66,796,897	6,685,844	11.12	2,218,958	15.03	1.1064
2017-05-12	2017-03-31	13F	TEVA PHARMACEUTICAL INDS	SPONSORED ADR	881624209	60,111,053	3,475,750	6.14	1,928,992	-6.04	0.9790
2017-02-14	2016-12-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	56,635,303	9,775,505	20.86	2,052,926	-4.78	1.0628
2016-11-14	2016-09-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	46,859,798	5,648,249	13.71	2,156,040	4.15	1.1273
2016-08-11	2016-06-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	41,211,549	4,389,590	11.92	2,070,095	5.06	1.1136
2016-05-10	2016-03-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	36,821,959	-4,140,536	-10.11	1,970,348	-26.72	1.0459
2016-04-27	2015-12-31	13F/A-1	TEVA PHARMACEUTICAL INDS	ADR	881624209	40,962,495	-6,954,803	-14.51	2,688,795	-0.61	1.3612
2016-02-12	2015-12-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	40,962,495			2,688,795
2015-11-10	2015-09-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	47,917,298	-2,204,102	-4.40	2,705,426	-8.67	1.3362
2015-08-12	2015-06-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	50,121,400	-4,925,570	-8.95	2,962,176	-13.62	1.3445
2015-05-14	2015-03-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	55,046,970	219,468	0.40	3,429,419	8.76	1.5549
2015-02-10	2014-12-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	54,827,502	-227,254	-0.41	3,153,134	6.55	1.4302
2014-11-12	2014-09-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	55,054,756	72,794	0.13	2,959,187	2.67	1.3497
2014-08-12	2014-06-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	54,981,962	5,708,606	11.59	2,882,143	10.70	1.2696
2014-05-13	2014-03-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	49,273,356	6,179,870	14.34	2,603,603	50.74	1.2295
2014-02-12	2013-12-31	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	43,093,486	21,877,679	103.12	1,727,186	115.49	0.8442
2013-11-14	2013-09-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	21,215,807	3,057,576	16.84	801,532	12.61	0.4266
2013-08-09	2013-06-30	13F	TEVA PHARMACEUTICAL INDS	ADR	881624209	18,158,231	18,158,231		711,803		0.4064

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.